This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should WisdomTree U.S. SmallCap Earnings Fund (EES) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for EES
Should WisdomTree U.S. SmallCap Earnings Fund (EES) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EES
Premier Inc. (PINC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Premier Inc. (PINC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should WisdomTree U.S. SmallCap Earnings Fund (EES) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for EES
Should WisdomTree U.S. SmallCap Earnings Fund (EES) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for EES
Should WisdomTree U.S. SmallCap Earnings Fund (EES) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for EES
Should WisdomTree U.S. SmallCap Earnings Fund (EES) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EES
Healthcare Stocks' Earnings Due on May 7: EVHC, PINC & More
by Zacks Equity Research
Acute flu, aging population, increase in patient volumes and high claims would affect healthcare companies' Q1 earnings.
Is Premier (PINC) a Great Stock for Value Investors?
by Nabaparna Bhattacharya
Let's see if Premier, Inc. (PINC) stock is a good choice for value-oriented investors right now from multiple angles.
New Strong Buy Stocks for February 13th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Why Earnings Season Could Be Great for Premier (PINC)
by Zacks Equity Research
Premier (PINC) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Masimo (MASI) Receives FDA Approval for SedLine, Shares Up
by Zacks Equity Research
Masimo (MASI) to overhaul neurological diagnoses with its next generation SedLine brain function monitoring.
New Strong Buy Stocks for January 26th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Is Premier (PINC) a Great Stock for Value Investors?
by Zacks Equity Research
Premier is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Falling Earnings Estimates Signal Weakness Ahead for PAREXEL (PRXL)
by Zacks Equity Research
PAREXEL (PRXL) is one stock you should avoid as it has seen a significant price decline and negative earnings estimate revisions.
Zacks.com featured highlights: Coherent, Premier, Teck Resources, Leucadia National and Seagate Technology
by Zacks Equity Research
Zacks.com featured highlights: Coherent, Premier, Teck Resources, Leucadia National and Seagate Technology
The Zacks Analyst Blog Highlights: Spark Energy, Investar Holding, CoreCivic, Premier and Taylor Morrison Home
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Spark Energy, Investar Holding, CoreCivic, Premier and Taylor Morrison Home
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Premier, Penumbra, DigitalGlobe and Sunrun
by Zacks Equity Research
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Premier, Penumbra, DigitalGlobe and Sunrun
5 High-Flying Stocks that Can Scale Higher
by Zacks Equity Research
Though skeptics may raise a brow on the mettle of this 52-week high investment strategy, we believe that this, when clubbed with the right set of parameters, will help rack up sizable gains.
Tame Market Volatility with 5 Low-Beta Stocks
by Zacks Equity Research
We have created a strategy wherein less risky stocks combined with some other parameters can generate handsome returns.
New Strong Buy Stocks for January 16th
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday